Quantinuum (NASDAQ:QNT) Given Overweight Rating at Cantor Fitzgerald

Quantinuum (NASDAQ:QNT)‘s stock had its “overweight” rating restated by analysts at Cantor Fitzgerald in a research report issued on Wednesday,Benzinga reports. They presently have a $90.00 price objective on the stock. Cantor Fitzgerald’s price target would indicate a potential upside of 60.54% from the stock’s current price.

Several other analysts have also recently issued reports on the company. UBS Group began coverage on Quantinuum in a research report on Monday, June 29th. They set a “buy” rating and a $93.00 target price on the stock. Bank of America started coverage on Quantinuum in a research report on Monday, June 29th. They set a “buy” rating and a $100.00 price objective on the stock. Zacks Research upgraded shares of Quantinuum to a “hold” rating in a report on Tuesday, June 30th. Wall Street Zen lowered shares of Quantinuum from a “hold” rating to a “sell” rating in a research report on Saturday, July 4th. Finally, Craig Hallum assumed coverage on shares of Quantinuum in a report on Monday, June 29th. They issued a “buy” rating and a $100.00 price target on the stock. Twelve analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $98.33.

Quantinuum Trading Down 0.9%

QNT stock opened at $56.06 on Wednesday. Quantinuum has a twelve month low of $47.06 and a twelve month high of $86.79. The company’s fifty day moving average price is $62.71.

Quantinuum (NASDAQ:QNT) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.02). The business had revenue of $8.00 million for the quarter. As a group, analysts anticipate that Quantinuum will post -1.61 EPS for the current fiscal year.

Insider Transactions at Quantinuum

In related news, insider Kevin Scott Dehoff acquired 15,000 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were purchased at an average cost of $60.00 per share, with a total value of $900,000.00. Following the completion of the acquisition, the insider directly owned 126,460 shares of the company’s stock, valued at $7,587,600. This represents a 13.46% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Joseph Jimenez bought 66,665 shares of Quantinuum stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average price of $60.00 per share, with a total value of $3,999,900.00. Following the purchase, the director directly owned 72,498 shares in the company, valued at $4,349,880. The trade was a 1,142.89% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought a total of 411,032 shares of company stock worth $24,661,920 over the last ninety days.

Institutional Trading of Quantinuum

A hedge fund recently bought a new position in Quantinuum stock. Lisanti Capital Growth LLC bought a new stake in shares of Quantinuum Inc. (NASDAQ:QNT) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 5,005 shares of the company’s stock, valued at approximately $409,000.

Key Quantinuum News

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum reported second-quarter revenue of $8 million, a 279% year-over-year increase, and raised its fiscal 2026 revenue outlook to $28 million-$32 million versus the $26.6 million analyst consensus. Quantinuum Reports Second Quarter 2026 Results
• Positive Sentiment: Quantinuum announced a multiyear partnership with Oracle (NYSE: ORCL) to deploy its 98-qubit Helios system in a U.S.-based Oracle Cloud Infrastructure AI data center. Customers will be able to access hybrid quantum-AI and high-performance computing capabilities through Oracle Cloud without owning specialized quantum hardware, potentially accelerating commercial adoption. Oracle, Quantinuum partner to bring quantum computing to cloud
• Positive Sentiment: The company said Helios demonstrated near five-nines logical fidelity, reinforcing Quantinuum’s positioning in fault-tolerant quantum computing. The Oracle deployment could provide an important bridge from technical milestones to applications such as drug discovery, materials science, financial modeling and optimization. Quantinuum Puts a 98-Qubit Helios Machine Inside Oracle’s AI Data Centers
• Negative Sentiment: Quantinuum reported an adjusted loss of $0.28 per share, slightly worse than the $0.26 consensus estimate. The earnings shortfall and the company’s still-small revenue base appear to have outweighed the favorable outlook and strategic partnership, helping explain why the stock finished lower. Quantinuum Reports Second Quarter 2026 Results

Quantinuum Company Profile

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.